Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States

por Gee, Julianne, Weinbaum, Cindy, Sukumaran, Lakshmi, Markowitz, Lauri E.
Publicado 2016

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States

por Stokley, Shannon, Curtis, C. Robinette, Jeyarajah, Jenny, Harrington, Theresa, Gee, Julianne, Markowitz, Lauri
Publicado 2013

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States

por Stokley, Shannon, Jeyarajah, Jenny, Yankey, David, Cano, Maria, Gee, Julianne, Roark, Jill, Curtis, C. Robinette, Markowitz, Lauri
Publicado 2014

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021

por Hause, Anne M., Baggs, James, Gee, Julianne, Marquez, Paige, Myers, Tanya R., Shimabukuro, Tom T., Shay, David K.
Publicado 2021

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system

por Chapin-Bardales, Johanna, Myers, Tanya, Gee, Julianne, Shay, David K., Marquez, Paige, Baggs, James, Zhang, Bicheng, Licata, Charles, Shimabukuro, Tom T.
Publicado 2021

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021

por Hause, Anne M., Gee, Julianne, Johnson, Tara, Jazwa, Amelia, Marquez, Paige, Miller, Elaine, Su, John, Shimabukuro, Tom T., Shay, David K.
Publicado 2021

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022

por Woo, Emily Jane, Gee, Julianne, Marquez, Paige, Baggs, James, Abara, Winston E., McNeil, Michael M., Dimova, Rositsa B., Su, John R.
Publicado 2023

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents

por Hanson, Kayla E., McLean, Huong Q., Belongia, Edward A., Stokley, Shannon, McNeil, Michael M., Gee, Julianne, VanWormer, Jeffrey J.
Publicado 2019

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US

por Hause, Anne M., Zhang, Bicheng, Yue, Xin, Marquez, Paige, Myers, Tanya R., Parker, Casey, Gee, Julianne, Su, John, Shimabukuro, Tom T., Shay, David K.
Publicado 2022

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study...

por Wong, Karen K, Heilig, Charles M, Hause, Anne, Myers, Tanya R, Olson, Christine K, Gee, Julianne, Marquez, Paige, Strid, Penelope, Shay, David K
Publicado 2022

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021

por Hause, Anne M., Baggs, James, Marquez, Paige, Myers, Tanya R., Gee, Julianne, Su, John R., Zhang, Bicheng, Thompson, Deborah, Shimabukuro, Tom T., Shay, David K.
Publicado 2021

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021

por Shay, David K., Gee, Julianne, Su, John R., Myers, Tanya R., Marquez, Paige, Liu, Ruiling, Zhang, Bicheng, Licata, Charles, Clark, Thomas A., Shimabukuro, Tom T.
Publicado 2021

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022

por Hause, Anne M., Baggs, James, Marquez, Paige, Myers, Tanya R., Su, John R., Hugueley, Brandon, Thompson, Deborah, Gee, Julianne, Shimabukuro, Tom T., Shay, David K.
Publicado 2022

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023

por Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Su, John R., Myers, Tanya R., Gee, Julianne, Panchanathan, Sarada S., Thompson, Deborah, Shimabukuro, Tom T., Shay, David K.
Publicado 2023

Epidemiology of Upper Limb Complex Regional Pain Syndrome in a Retrospective Cohort of Persons Aged 9–30 Years, 2002–2017

por Naleway, Allison L, Henninger, Michelle L, Irving, Stephanie A, Bianca Salas, S, Kauffman, Tia L, Crane, Bradley, Mittendorf, Kathleen F, Harsh, Stacy, Elder, Charles, Gee, Julianne
Publicado 2023

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents

por VanWormer, Jeffrey J., Bendixsen, Casper G., Vickers, Elizabeth R., Stokley, Shannon, McNeil, Michael M., Gee, Julianne, Belongia, Edward A., McLean, Huong Q.
Publicado 2017

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022

por Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Myers, Tanya R., Gee, Julianne, Su, John R., Parker, Casey, Thompson, Deborah, Panchanathan, Sarada S., Shimabukuro, Tom T., Shay, David K.
Publicado 2022

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022

por Hause, Anne M., Baggs, James, Marquez, Paige, Abara, Winston E., Olubajo, Babatunde, Myers, Tanya R., Su, John R., Thompson, Deborah, Gee, Julianne, Shimabukuro, Tom T., Shay, David K.
Publicado 2022

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022

por Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Myers, Tanya R., Gee, Julianne, Su, John R., Blanc, Phillip G., Thomas, Alisha, Thompson, Deborah, Shimabukuro, Tom T., Shay, David K.
Publicado 2022

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022...

por Hause, Anne M., Baggs, James, Marquez, Paige, Abara, Winston E., Baumblatt, Jane Gwira, Thompson, Deborah, Su, John R., Myers, Tanya R., Gee, Julianne, Shimabukuro, Tom T., Shay, David K.
Publicado 2022